Welcome to our dedicated page for Hippo Hldgs SEC filings (Ticker: HIPOW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Hippo Hldgs's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Hippo Hldgs's regulatory disclosures and financial reporting.
An insider of the company with ticker HIPO has filed a notice to sell 3,900 shares of its common stock through broker Morgan Stanley Smith Barney LLC on the NYSE. The planned sale has an aggregate market value of $120,471.00, compared with 25,335,179 shares outstanding of the same class. The securities to be sold were acquired from the issuer as restricted stock units and performance stock units on 08/15/2025 and 09/10/2025, in amounts of 2,627 and 1,273 shares respectively, with payment noted as non-cash. The filer represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.
Hippo Holdings Inc. director reports charitable stock gift
A director of Hippo Holdings Inc. reported donating 4,935 shares of common stock on 12/18/2025 in a transaction coded as a gift at a price of $0.00 per share. After this donation, the director beneficially owns 16,563 shares of common stock directly, including 4,738 restricted stock units, and 50,000 shares indirectly through Janajasa Associates L.P. The filing reflects a personal charitable transfer rather than an open-market sale.
Hippo Holdings Inc. insider activity: Chief Executive Officer and director Richard McCathron reported selling 5,000 shares of Hippo common stock on 12/09/2025 at a price of $29.82 per share. The sale was carried out under a pre-arranged Rule 10b5-1 trading plan dated August 29, 2025, which is designed to allow insiders to sell shares according to a preset schedule. Following this transaction, McCathron beneficially owns 452,704 shares of Hippo common stock, which includes 181,675 restricted stock units (RSUs).
Hippo Holdings Inc. has a planned sale of restricted stock reported under Rule 144. The notice covers up to 5,000 shares of common stock to be sold through Merrill Lynch on the NYSE, with an aggregate market value of
The filing states that 25,335,179 shares of the issuer’s common stock were outstanding, providing context on the size of the planned sale relative to the overall share base. The approximate sale date listed is
Hippo Holdings (HIPO) has a Form 144 notice covering a planned sale of 3,645 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE. The shares have an aggregate market value of
Hippo Holdings Inc. (HIPO)2,463 shares of common stock at $31.1137 per share was reported. After this transaction, Stienstra beneficially owned 75,181 shares, which includes 37,874 restricted stock units (RSUs). The filing reflects routine reporting of changes in an executive’s equity holdings.
Hippo Holdings Inc. (HIPO)11/15/2025, the reporting person disposed of 2,123 shares of common stock in a transaction marked with code F at a price of $31.1137 per share. After this transaction, the reporting person beneficially owned 58,852 shares of Hippo common stock.
The reported holdings include 47,549 restricted stock units (RSUs), indicating that a significant portion of the position is in the form of equity awards that typically settle into shares over time.
Hippo Holdings Inc. (HIPO) reported that Chief Executive Officer and director Richard McCathron disposed of 11,326 shares of common stock on 11/15/2025 at a price of $31.1137 per share. After this transaction, he beneficially owns 457,704 shares of Hippo common stock, which the disclosure states includes 181,675 restricted stock units (RSUs). The filing is made on Form 4 as a single-reporting-person filing for McCathron in his roles as both director and officer.
HIPO filed a Form 144 covering a planned sale of 1,819 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $57,371.26. These shares come from restricted stock units acquired from the issuer on 11/15/2025, with payment also dated 11/15/2025. The filing notes that 25,335,179 shares of common stock were outstanding, providing a baseline for the company’s total equity. Over the prior three months, a Rule 10b5-1 trading plan for Guy Zeltser reported sales of 5,177 common shares for gross proceeds of $194,031.73.
Hippo Holdings (HIPO): Lennar Corporation and affiliated entities filed Amendment No. 4 to Schedule 13D reporting beneficial ownership of 2,169,580 shares of Hippo common stock, representing 8.6% of outstanding shares. The percentage is based on 25,335,179 shares outstanding as of October 29, 2025. One reporting person also holds an irrevocable proxy to vote 16,470 shares, while an agreement limits voting decisions to no more than 9.99% of Hippo’s voting interests.
The filing lists recent open‑market sales by LEN FW Investor, LLC: 119,780 shares on November 7, 2025 at a weighted‑average price of $33.87, and 62,058 shares on November 10, 2025 at $33.59, with additional sales on November 11 and 12, 2025 at weighted‑average prices of $33.22 and $34.06.
FAQ
What is the current stock price of Hippo Hldgs (HIPOW)?
